RegMed Europe – Paris, France – 7th July 2017
Ann Kramer and Brendan Robb will be at RegMed Europe: The 1st European matchmaking event on regenerative medicine in Paris on 7th July 2017. One to One meeting booking available from mid June.
Mixiii Biomed – Tel Aviv – 23-25 May 2017
Ann Kramer and Rob McKean will attend the 16th annual MIXiii-Biomed conference and exhibition to be held May 23-15 in Tel Aviv, Israel.
AACR – Washington D.C. – 1-5 April 2017
AMS Biotechnology (@AMS_bio) will be showcasing Mimetix scaffolds for 3D culture of cancer cells at the Annual Association of Cancer Research Annual meeting in Washington D.C. from 1-5 April. Visit booth #3522.
Angels in MedCity – Oxford Information evening – 28th March 2017
CEO Ann Kramer will talk at the Angels in MedCity – Oxford Information Evening 28 March 2017, 17:00 – 20:00 Penningtons Manches Oxford, 9400 Garsington Road, Oxford Business Park, OX4 2HN MedCity in conjunction with Penningtons Manches would like to invite you to an information evening about the Angels in MedCity initiative. The event will… Read more »
ELRIG Research and Innovation – Cambridge – 29 – 30 March 2017
Dr Gary Allenby of Aurelia Bioscience will present the results of a collaborative development project at the European Laboratory Research and Innovation ELRIG 5th Annual Research & Innovation Meeting. Gary will present at 14:30 on 30th March on “3-Dimensional electrospun scaffold-based biological assays – A practical approach to performing 3-D cell culture and assays in microwell plates”…. Read more »
ISSCR stem cell Basel 27 Feb – 01 Mar 2017
Visit the AMSBio stand to learn more about Mimetix scaffolds for stem cell growth and differentiation. . The theme is Translational Opportunities in Stem Cell Research, it will explore the latest translational opportunities in the stem cell field, cutting-edge technology helping to drive the research, and inspired perspectives on where the area of research is… Read more »
Electrospinning secures Angel investment to drive growth
The Electrospinning Company Announces £650,000 Funding Round Harwell, UK — 26 January 2017 — The Electrospinning Company, announces that it has secured a £650,000 investment to establish itself as the leading provider of clinical-grade electrospun biomaterials to the medical device industry. Funding has come from a network of UK angel investors, including Angels 5K, LBA,… Read more »
SLAS 2017 Washington D.C. – 4-8 Feb 2017
SLAS 2017: Visit AMS Biotechnology at stand 1723 to discuss Mimetix scaffolds for 3D cell culture and myelination assays.
Future of Healthcare Investor Forum – 26 January 2017 – London stock exchange
Ann Kramer and Drummond Paris will be at the 3rd Annual Future of Healthcare Investor Forum with an exhibition stand. The event, sponsored by J.P. Morgan, Numis, Penningtons Manches, PwC and Consilium Strategic Communications, and held in partnership with the MedCity, BioIndustry Association (BIA) and One Nucleus, will highlight the significant investment opportunities within the UK… Read more »
MeDe Innovation – Bradford, UK – 19th Jan 2017
Dr Brendan Robb will attend the fourth annual MeDe Innovation Conference and would be pleased to discuss the application of electrospun scaffolds to orthopaedic regenerative device challenges. The MeDe Innovation Annual Conference is a unique opportunity to access the latest developments in orthopaedic medical device manufacture. The conference brings together MeDe Innovation’s network of academics,… Read more »
3D tumour environment affects DNA damage
In “Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase. Joanne Wayne, Teresa Brooks, Andrew J. Massey. DOI: 10.18632/oncotarget.13119″ Vernalis researchersfollowed the regulation of the Chk1 and Chk6 kinases in various human tumour cell lines grown in 2D conditions, spheroids and Mimetix scaffolds and compared… Read more »
Electrospinning Company strengthens the Board
The Electrospinning Company has appointed two new members to its Board of Directors to help develop its strategy and drive its growing business in the regenerative medical device sector. Drummond Paris and Nigel Edwards join Kate Ronayne (representing STFC Innovations), Malcolm Chapman (Angel investor) and Ann Kramer (CEO) as well as observer Mark White (Rainbow Seed… Read more »